Trial intelligence / Profile preview

Safety and efficacy of vardenafil in patients with liver cirrhosis

2010-023420-25Phase 4Terminated

Sponsor
Medical University of Vienna, Department of Internal Medicine IV
Start
Jul 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of vardenafil in erectile dysfunction (ED), sponsored by Medical University of Vienna, Department of Internal Medicine IV. Primary endpoints: Change in hepatic venous pressure gradient (HVPG) and IIEF-5 score of erectile dysfunction. Started Jul 2011; status: terminated.

02

Drugs

vardenafil
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on 2010-023420-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-023420-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call